Volume-controlled lung lavage in the treatment of asthma, bronchiectasis, and mucoviscidosis.
D000142:Acidosis, Respiratory / Q000209:etiology; D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000628:therapy*; D001987:Bronchiectasis / Q000628:therapy*; D002245:Carbon Dioxide / Q000097:blood; D003327:Coronary Disease / Q000209:etiology; D003550:Cystic Fibrosis / Q000628:therapy*; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D006982:Hypertonic Solutions; D008297:Male; D010100:Oxygen / Q000097:blood; D011655:Pulmonary Embolism / Q000209:etiology; D013147:Spirometry; D007507:Therapeutic Irrigation / Q000009:adverse effects; D014692:Ventilation-Perfusion Ratio
D006982:Hypertonic Solutions; D002245:Carbon Dioxide; D010100:Oxygen